It is important to distinguish between excessive supplementation and pathologically elevated B12 levels, which may indicate underlying haematological disorders, liver disease, or renal impairment rather than true overdose
Elevated MMA can be a marker for low B12
While its not harmful, taking oral BPC-157 with food will likely reduce its bioavailability
Clinical Symptoms Indicating Treatment Need Spotting vitamin B12 deficiency symptoms early is critical
This behaviour is consistent with the fragment-sized nature of the compounds, which at this early stage lack extensive non-covalent secondary interactions and may therefore modify multiple accessible cysteine residues, and is in line with MAP2K6 in chemoproteomic data that identified labelling multiple cysteine sites 65,66,67,68,69